임상시험 공급 및 물류 시장 : 서비스, 조달 모델, 유형, 배송 형태, 최종사용자, 치료 영역, 임상시험 단계별 - 세계 예측(2025-2030년)

The Clinical Trial Supply & Logistics Market was valued at USD 24.33 billion in 2023 and is projected to grow to USD 26.20 billion in 2024, with a CAGR of 7.75%, reaching USD 41.04 billion by 2030.

In today's fast-paced environment, the clinical trial supply and logistics sector stands as a vital cog in the drug development process. The once traditional methods are rapidly evolving to address an increasingly demanding landscape, characterized by complex research protocols, heightened regulatory requirements, and a global network of clinical sites. This report offers a comprehensive overview of the state-of-the-art methodologies emerging in the industry and sets the stage for an in-depth examination of market dynamics. The narrative is built on the convergence of cutting-edge technologies, innovative sourcing strategies, and adaptive logistics solutions that cater to the nuances of clinical trials at every stage. Recognizing the importance of maintaining both the integrity and timely delivery of sensitive trial materials, industry leaders have been compelled to reimagine their supply chains. As the industry moves towards a more integrated and holistic approach, every facet-from manufacturing and packaging to labeling and storage-has come under scrutiny. The discussion highlights the progressive steps taken by various stakeholders to streamline operations, ensuring that novel therapies reach those in need efficiently and safely.

Transformative Shifts Reshaping the Clinical Trial Landscape

Over recent years, the industry has witnessed several transformative shifts that have redefined how clinical trial supplies are managed. Advancements in digital connectivity, combined with robust data analytics, have paved the way for more predictive and responsive logistic strategies. Stakeholders are increasingly leveraging cloud-based platforms and real-time tracking systems that offer unparalleled visibility into the supply chain. This not only minimizes the risk of disruption but also enhances decision-making processes at every juncture. A move towards sustainable and agile operations has further spurred innovations in temperature-controlled logistics, ensuring that sensitive biological materials maintain their integrity during transit. Moreover, collaborations across sectors have led to the integration of advanced manufacturing techniques and automated packaging processes. Such changes have resulted in operational efficiencies that ripple throughout the clinical trial landscape. As techniques evolve, the boundaries between traditional roles blur, ushering in a convergence of expertise that optimizes the balance between cost management and quality assurance. These transformative shifts are laying the foundation for a supply ecosystem that is both resilient and responsive to the dynamic needs of modern clinical trials.

Key Segmentation Insights Driving Market Dynamics

A refined understanding of the market segmentation is paramount for deciphering the intricate dynamics of clinical trial supply and logistics. The analysis is categorized under various dimensions beginning with the services provided. The market is dissected across facets including comparator sourcing, comprehensive logistics and distribution, precise manufacturing, detailed packaging, accurate labeling and blinding, as well as critical storage and retention. Within logistics, the evolution is further delineated into cold chain distribution methods that are essential for maintaining temperature-sensitive biologics and non-cold chain distribution options catering to a broader spectrum of medical products. Additionally, sourcing models are scrutinized with a focus on centralized versus decentralized approaches, each presenting unique benefits in terms of efficiency and cost optimization. Critical market differentiation also emerges when examining the types of products, spanning biologic drugs, advanced medical devices, and small molecule therapies. Furthermore, the mode of delivery is scrutinized by contrasting offsite supply management against onsite supply management, which has significant implications on timing and resource allocation. End-user analysis extends from contract research organizations and medical devices companies to pharmaceutical and biotechnology companies, underscoring the diverse and specialized needs of various stakeholders. Lastly, therapeutic areas from blood disorders to respiratory challenges, complemented by an evaluation of multiple phases of clinical trials from BA/BE studies through Phase 4, provide a nuanced lens through which market needs and opportunities can be accurately assessed.

Based on Services, market is studied across Comparator Sourcing, Logistics & Distribution, Manufacturing, Packaging, Labeling, & Blinding, and Storage & Retention. The Logistics & Distribution is further studied across Cold Chain Distribution and Non-Cold Chain Distribution.

Based on Sourcing Model, market is studied across Centralized Sourcing and Decentralized Sourcing.

Based on Type, market is studied across Biologic Drugs, Medical Devices, and Small Molecules.

Based on Mode of Delivery, market is studied across Offsite Supply Management and Onsite Supply Management.

Based on End-user, market is studied across Contract Research Organisations, Medical Devices Companies, and Pharmaceutical & Biotechnology Companies.

Based on Therapeutic Area, market is studied across Blood Disorders, Cardiovascular Diseases, CNS & Mental Disorders, Dermatological Disorders, Digestive Disorders, ENT Diseases, Immunology, Infectious Diseases, Metabolic Disorders, Nephrology, Oncology, Rare Diseases, and Respiratory Disorders.

Based on Phases of Clinical Trials, market is studied across BA/ BE studies, Phase 1, Phase 2, Phase 3, and Phase 4.

Regional Dynamics and Market Opportunities

The clinical trial supply and logistics market is visibly segmented by distinct regional trends that influence strategic decisions and operational frameworks. In the Americas, mature regulatory landscapes and advanced healthcare infrastructures are propelling market growth, with a particular focus on innovations that improve trial efficiencies and reduce lead times. Meanwhile, the combined dynamics of Europe, the Middle East, and Africa present a compelling mix of regulatory rigor and emerging opportunities. These regions are harnessing the benefits of technological integration and collaborative supply chain practices to tackle unique challenges intrinsic to local healthcare systems. The Asia-Pacific region is rapidly asserting its position on the global stage as an epicenter for clinical research and development. Driven by substantial investments in research infrastructure and a vast patient demographic pool, the region is witnessing remarkable improvements in logistics capabilities and an increasing adoption of technology-driven solutions. In each of these markets, the balance between localized operational strategies and global best practices is key to sustaining momentum and fostering growth. Understanding these geographical nuances not only enhances the ability to anticipate market shifts but also empowers stakeholders to design region-specific strategies that align with broader global trends.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, Massachusetts, Minnesota, New York, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Leading Players and Competitive Strategies

The market landscape is further enriched by a competitive array of key companies that have robustly positioned themselves at various stages of the clinical trial supply chain. Companies such as Acnos Pharma GmbH and ADAllen Pharma Ltd have developed specialized capabilities in supply chain management, while industry leaders including Almac Group Limited, Ancillare, LP, and Avantor, Inc. continue to push boundaries with innovative logistical solutions. Other notable players such as Beroe Holdings Inc. and Biocair International Limited are known for their stringent quality controls and reliable distribution networks. The competitive environment is bolstered by significant contributions from Calyx, Catalent, Inc., and Clinical Services International LTD, along with influential operations led by Clinigen Group PLC and COREX LOGISTICS LIMITED. Furthermore, global logistics giants like DHL Group, FedEx Corporation, and Tower Cold Chain Solutions are instrumental in driving supply chain optimization. In this complex ecosystem, organizations including Eurofins Scientific SE, Experic, LLC, ICON PLC, and Inceptua S.A. have also emerged as front-runners. The presence of technology powerhouses such as Infosys Limited and SAP SE, combined with strong performances from specialized entities like IPS Pharma and KLIFO A/S, enriches the competitive tapestry. Collectively, these players contribute to a dynamic market environment that rewards innovation, operational excellence, and a commitment to sustained improvement in clinical supply chain processes.

The report delves into recent significant developments in the Clinical Trial Supply & Logistics Market, highlighting leading vendors and their innovative profiles. These include Acnos Pharma GmbH, ADAllen Pharma Ltd, Almac Group Limited, Ancillare, LP, Avantor, Inc., Beroe Holdings Inc., Biocair International Limited, Calyx, Catalent, Inc., Clinical Services International LTD, Clinigen Group PLC, COREX LOGISTICS LIMITED, DHL Group, Eurofins Scientific SE, Experic, LLC, FedEx Corporation, ICON PLC, Inceptua S.A., Infosys Limited, IPS Pharma, KLIFO A/S, Lonza Group AG, Marken Limited by United Parcel Service, Inc., Microsoft Corporation, Myonex, Inc., N-SIDE SA, NUVISAN GmbH, OCT Clinical GmbH, Octalsoft, Parexel International Corporation, PCI Pharma Services, PHOENIX Pharmahandel GmbH & Co KG, Piramal Pharma Limited, Recipharm AB, SAP SE, Sharp Services, LLC, Signant Health, SIRO Clinpharm Private Limited, Thermo Fisher Scientific Inc., Tower Cold Chain Solutions, Uniphar PLC, Walden Group, and Zuellig Pharma Pte Ltd by Interpharma Investments Limited. Actionable Recommendations for Advancing Market Leadership

Industry leaders are encouraged to embrace a multi-pronged approach to secure a competitive edge and streamline operations in a rapidly evolving market. First, there is an immediate need to invest in digital transformation initiatives, including the integration of real-time tracking systems and advanced analytics platforms to foster greater supply chain visibility and risk mitigation. It is essential to cultivate partnerships that bridge the gaps between manufacturing, packaging, and distribution, ensuring that the entire supply chain remains cohesive and resilient. Emphasizing a shift towards centralized or, where beneficial, decentralized sourcing strategies can help optimize resource allocation and manage regional demands effectively. Furthermore, aligning with specialized service providers that offer bespoke solutions across comparator sourcing and cold chain logistics will fortify the ability to handle sensitive trial materials. Leaders should also consider diversifying their operational frameworks by leveraging offsite and onsite supply management models that accommodate the evolving requirements of varied therapeutic areas and clinical trial phases. Strategic investments in automation, data analytics, and sustainable logistic practices can dramatically reduce turnaround times while enhancing cost efficiency. Embracing these actionable strategies not only reinforces current operational frameworks but also positions organizations to anticipate future market challenges with agility and precision.

Conclusion and Forward Outlook

In summary, the clinical trial supply and logistics market is undergoing a significant transformation driven by technological advancements and innovative operational strategies. The integrated approach to managing segmented market needs-from services and sourcing models to therapeutic areas and trial phases-underscores a deep commitment to enhancing efficiency and ensuring the successful execution of clinical research. As regional markets evolve and competitive pressures intensify, a strategic, data-informed, and agile methodology remains a critical success factor. The momentum generated by these evolving trends paints an optimistic future where operational excellence and technological integration coalesce to drive transformative outcomes across the industry.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Globalization of clinical trials and harmonization of regulations
    • 5.1.1.2. Rising government funds to strengthen pharmaceutical R&D activities across economies with increasing incidence of chronic diseases
  • 5.1.2. Restraints
    • 5.1.2.1. Problems associated with technology integration and data management
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing partnership activities between pharmaceutical manufacturers and CDMOs
    • 5.1.3.2. Integration of artificial intelligence and machine learning for predictive analytics in supply chain optimization
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns associated with the operations within clinical trial supply and logistics
• 5.2. Market Segmentation Analysis
  • 5.2.1. Services: Continuous advancements in cold chain distribution services with growing demand
  • 5.2.2. Type: Surging utilization of small molecules in the pharmaceutical sector
  • 5.2.3. Mode of Delivery: Growing adoption of offsite solutions for multi-site trials delivery
  • 5.2.4. Sourcing Model: Rising demand for decentralized sourcing models to enhance the speed and efficiency of supply distribution
  • 5.2.5. Phase: Increasing scope of supply & logistics services in phase 3 clinical trials
  • 5.2.6. Therapeutic Area: Proliferating private and public sector investments and research activities in oncology
  • 5.2.7. End User: Rising use of clinical trial supply & logistics by pharmaceutical & biotechnology companies
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Clinical Trial Supply & Logistics Market, by Services

• 6.1. Introduction
• 6.2. Comparator Sourcing
• 6.3. Logistics & Distribution
  • 6.3.1. Cold Chain Distribution
  • 6.3.2. Non-Cold Chain Distribution
• 6.4. Manufacturing
• 6.5. Packaging, Labeling, & Blinding
• 6.6. Storage & Retention

7. Clinical Trial Supply & Logistics Market, by Sourcing Model

• 7.1. Introduction
• 7.2. Centralized Sourcing
• 7.3. Decentralized Sourcing

8. Clinical Trial Supply & Logistics Market, by Type

• 8.1. Introduction
• 8.2. Biologic Drugs
• 8.3. Medical Devices
• 8.4. Small Molecules

9. Clinical Trial Supply & Logistics Market, by Mode of Delivery

• 9.1. Introduction
• 9.2. Offsite Supply Management
• 9.3. Onsite Supply Management

10. Clinical Trial Supply & Logistics Market, by End-user

• 10.1. Introduction
• 10.2. Contract Research Organisations
• 10.3. Medical Devices Companies
• 10.4. Pharmaceutical & Biotechnology Companies

11. Clinical Trial Supply & Logistics Market, by Therapeutic Area

• 11.1. Introduction
• 11.2. Blood Disorders
• 11.3. Cardiovascular Diseases
• 11.4. CNS & Mental Disorders
• 11.5. Dermatological Disorders
• 11.6. Digestive Disorders
• 11.7. ENT Diseases
• 11.8. Immunology
• 11.9. Infectious Diseases
• 11.10. Metabolic Disorders
• 11.11. Nephrology
• 11.12. Oncology
• 11.13. Rare Diseases
• 11.14. Respiratory Disorders

12. Clinical Trial Supply & Logistics Market, by Phases of Clinical Trials

• 12.1. Introduction
• 12.2. BA/ BE studies
• 12.3. Phase 1
• 12.4. Phase 2
• 12.5. Phase 3
• 12.6. Phase 4

13. Americas Clinical Trial Supply & Logistics Market

• 13.1. Introduction
• 13.2. Argentina
• 13.3. Brazil
• 13.4. Canada
• 13.5. Mexico
• 13.6. United States

14. Asia-Pacific Clinical Trial Supply & Logistics Market

• 14.1. Introduction
• 14.2. Australia
• 14.3. China
• 14.4. India
• 14.5. Indonesia
• 14.6. Japan
• 14.7. Malaysia
• 14.8. Philippines
• 14.9. Singapore
• 14.10. South Korea
• 14.11. Taiwan
• 14.12. Thailand
• 14.13. Vietnam

15. Europe, Middle East & Africa Clinical Trial Supply & Logistics Market

• 15.1. Introduction
• 15.2. Denmark
• 15.3. Egypt
• 15.4. Finland
• 15.5. France
• 15.6. Germany
• 15.7. Israel
• 15.8. Italy
• 15.9. Netherlands
• 15.10. Nigeria
• 15.11. Norway
• 15.12. Poland
• 15.13. Qatar
• 15.14. Russia
• 15.15. Saudi Arabia
• 15.16. South Africa
• 15.17. Spain
• 15.18. Sweden
• 15.19. Switzerland
• 15.20. Turkey
• 15.21. United Arab Emirates
• 15.22. United Kingdom

16. Competitive Landscape

• 16.1. Market Share Analysis, 2023
• 16.2. FPNV Positioning Matrix, 2023
• 16.3. Competitive Scenario Analysis
  • 16.3.1. Catalent strengthens European supply chain with USD 25 million expansion of Schorndorf facility, enhancing FastChain capabilities
  • 16.3.2. Experic strategically expands to Europe with a new Dublin facility enhancing global clinical trial supply and logistics services
  • 16.3.3. FedEx fortifies its global clinical trial logistics with a new life science center in Mumbai, enhancing healthcare supply chain connectivity
  • 16.3.4. PCM Trials acquires Netherlands-based clinical trial service
  • 16.3.5. Piramal Pharma solutions commemorates opening of its ADC manufacturing expansion in Grangemouth, Scotland
  • 16.3.6. Biocair announces the U.S. expansion as part Of global growth strategy
  • 16.3.7. Vaxcyte and Lonza sign new commercial manufacturing agreement for PCVs
  • 16.3.8. Piramal Pharma Solutions launches in-vitro biology capabilities at Ahmedabad discovery services site
  • 16.3.9. Signant Health Launches Signant Biotech to accelerate and streamline clinical development for emerging biopharmaceutical organizations
  • 16.3.10. N-SIDE introduces Lighthouse, innovative software to shape the future of worldwide clinical trial supply management
  • 16.3.11. Zuellig Pharma and GSK establish a vaccine distribution hub in Singapore
  • 16.3.12. Ariceum Therapeutics and Eurofins CDMO sign a pharmaceutical multi-project agreement
  • 16.3.13. Vial announces strategic partnership with Royale International Group
  • 16.3.14. Biocair partners with TrakCel to improve visibility in the supply chain
  • 16.3.15. IDEAYA expands clinical trial collaboration and supply agreements with Pfizer
  • 16.3.16. Calyx introduces new clinical trial supply forecasting service
  • 16.3.17. Catalent completes expansion of Singapore clinical supply facility for increased temperature-controlled capabilities
• 16.4. Strategy Analysis & Recommendation
  • 16.4.1. Almac Group Limited
  • 16.4.2. Catalent, Inc.
  • 16.4.3. DHL Group
  • 16.4.4. Walden Group

Companies Mentioned

• 1. Acnos Pharma GmbH
• 2. ADAllen Pharma Ltd
• 3. Almac Group Limited
• 4. Ancillare, LP
• 5. Avantor, Inc.
• 6. Beroe Holdings Inc.
• 7. Biocair International Limited
• 8. Calyx
• 9. Catalent, Inc.
• 10. Clinical Services International LTD
• 11. Clinigen Group PLC
• 12. COREX LOGISTICS LIMITED
• 13. DHL Group
• 14. Eurofins Scientific SE
• 15. Experic, LLC
• 16. FedEx Corporation
• 17. ICON PLC
• 18. Inceptua S.A.
• 19. Infosys Limited
• 20. IPS Pharma
• 21. KLIFO A/S
• 22. Lonza Group AG
• 23. Marken Limited by United Parcel Service, Inc.
• 24. Microsoft Corporation
• 25. Myonex, Inc.
• 26. N-SIDE SA
• 27. NUVISAN GmbH
• 28. OCT Clinical GmbH
• 29. Octalsoft
• 30. Parexel International Corporation
• 31. PCI Pharma Services
• 32. PHOENIX Pharmahandel GmbH & Co KG
• 33. Piramal Pharma Limited
• 34. Recipharm AB
• 35. SAP SE
• 36. Sharp Services, LLC
• 37. Signant Health
• 38. SIRO Clinpharm Private Limited
• 39. Thermo Fisher Scientific Inc.
• 40. Tower Cold Chain Solutions
• 41. Uniphar PLC
• 42. Walden Group
• 43. Zuellig Pharma Pte Ltd by Interpharma Investments Limited